Nutra Pharma Announces Collaboration With Nationwide Laboratories - Yahoo Singapore News
| NPHC Stock | USD 0.0001 0.00 0.00% |
About 55% of Nutra Pharma's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Nutra Pharma Corp pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Nutra Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Nutra Pharma Corp stock news signals to limit their universe of possible portfolio assets.
Nutra |
Nutra Pharma Announces Collaboration With Nationwide Laboratories Yahoo Singapore News
Read at news.google.com
 |
Nutra Pharma Fundamental Analysis
We analyze Nutra Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Nutra Pharma is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Peers
Trending Equities
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |